IMNM logo

Immunome (IMNM) Company Overview

Profile

Full Name:

Immunome, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 2, 2020

Indexes:

Not included

Description:

IMNM (Immunome) is a biotechnology company focused on developing innovative therapies for cancer and infectious diseases. They use advanced technologies to discover and create immune-based treatments, aiming to improve patient outcomes and enhance the body's natural defense mechanisms against diseases.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 14, 24 Piper Sandler
Overweight
Nov 8, 24 Stephens & Co.
Overweight
Oct 25, 24 Wedbush
Outperform
Aug 13, 24 Wedbush
Outperform
Aug 13, 24 Piper Sandler
Overweight
May 31, 24 Piper Sandler
Overweight
Apr 30, 24 JP Morgan
Overweight
Apr 15, 24 Guggenheim
Buy
Apr 1, 24 Wedbush
Outperform
Jan 23, 24 Wedbush
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Immunome?
  • Does Immunome pay dividends?
  • What sector is Immunome in?
  • What industry is Immunome in?
  • What country is Immunome based in?
  • When did Immunome go public?
  • Is Immunome in the S&P 500?
  • Is Immunome in the NASDAQ 100?
  • Is Immunome in the Dow Jones?
  • When was Immunome's last earnings report?
  • When does Immunome report earnings?
  • Should I buy Immunome stock now?

What is the ticker symbol for Immunome?

The ticker symbol for Immunome is NASDAQ:IMNM

Does Immunome pay dividends?

No, Immunome does not pay dividends

What sector is Immunome in?

Immunome is in the Healthcare sector

What industry is Immunome in?

Immunome is in the Biotechnology industry

What country is Immunome based in?

Immunome is headquartered in United States

When did Immunome go public?

Immunome's initial public offering (IPO) was on October 2, 2020

Is Immunome in the S&P 500?

No, Immunome is not included in the S&P 500 index

Is Immunome in the NASDAQ 100?

No, Immunome is not included in the NASDAQ 100 index

Is Immunome in the Dow Jones?

No, Immunome is not included in the Dow Jones index

When was Immunome's last earnings report?

Immunome's most recent earnings report was on Nov 13, 2024

When does Immunome report earnings?

The next expected earnings date for Immunome is Mar 28, 2025

Should I buy Immunome stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions